We show that pegcetacoplan improves biomarkers of iron overload, including reduced transferrin saturation, increased hepcidin concentrations, and decreased ARCs, by blocking both IVH and EVH and preventing anemia. The gene discussed is TF; the disease is anemia (phenotype).